Search for: "Johnson v. Administrator" Results 101 - 120 of 1,937
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Apr 2011, 4:05 am
OATH Administrative Law Judge John Spooner rejected the correction officer’s theory and found that the tests had been properly conducted. [read post]
8 Mar 2010, 2:40 am by sally
Court of Appeal (Criminal Division) Johnson, R. v [2010] EWCA Crim 385 (04 March 2010) Court of Appeal (Civil Division) Houldsworth & Anor v Bridge Trustees Ltd & Anor [2010] EWCA Civ 179 (04 March 2010) Malik v Kalyan [2010] EWCA Civ 113 (04 March 2010) High Court (Chancery Division) Vercoe & Ors v Rutland Fund Management Ltd & Ors [2010] EWHC 424 (Ch) (05 March 2010) Bellway Homes Ltd v Beazer Homes Ltd [2010] EWHC 423 (Ch)… [read post]
30 Oct 2014, 9:05 pm by Walter Olson
Brasier, Detroit Free Press] Case against deference: “Now More Than Ever, Courts Should Police Administrative Agencies” [Ilya Shapiro on Perez v. [read post]
29 May 2024, 11:13 am by Ryan Snyder
Circuit published one administrative-law opinion last week: Novartis Pharmaceuticals Corp. v. [read post]
25 Jun 2010, 4:06 am
Having a residence in the jurisdiction not always the same as having a domicile in the jurisdictionMatter of Johnson v Town of Amherst, 2010 NY Slip Op 05447, Decided on June 18, 2010, Appellate Division, Fourth DepartmentThe Town of Amherst’s Town Code required its employees to be “domiciliaries of the Town. [read post]
As mentioned in our recent blog post, the recently filed class action lawsuit against Johnson & Johnson (Lewandowski v. [read post]
2 Apr 2012, 7:22 am by Eleanor Winslet
Mr Campbell worked for Johnson Controls providing a taxi administration service for the United Kingdom Atomic Energy Authority (“UKAEA”). [read post]
7 Nov 2013, 11:24 pm by Jon Gelman
On Monday, Johnson & Johnson announced that it would be paying more than $2.2 billion to resolve civil and criminal claims relating to allegations that the company marketed Risperdal, a drug primarily designed to treat bi-polar disorder and schizophrenia, for uses other than those approved by the Food and Drug Administration. [read post]